Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2 clinical trials
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)

brain metastases
gilbert's syndrome
irinotecan
pembrolizumab
estrogen
  • 8 views
  • 05 Aug, 2020
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.

x-rays
ascites
plain x-ray
non-target
x rays
  • 0 views
  • 16 Feb, 2024
  • 1 location